Ranjit Manchanda, Co-Lead of Screening Prevention and Epidemiology Unit, Wolfson Institute of Population Health at Queen Mary University of London, shared a post on LinkedIn:
“Delighted to see this announcement.
Fantastic news which will enable prevention of many more cancers and many more lives being saved. It has been the culmination of a long journey of population BRCA testing in the Jewish community which started in 2008, encompassing a PhD, multiple papers, a NHS Innovation accelerator fellowship, working with NICE, and engagement and working the NHS England Cancer Programme team and multiple stakeholders for programme development and implementation.
A massive thank you to the huge number of colleagues, researchers, stakeholders, clinicians, health professionals, NHS Innovation Accelerator, NHS England Cancer Programme team, the ICR NHS-JBRCA team, North Thames GMSA team, community charities, community leadership, cancer charities and multiple stakeholders involved with supporting these efforts over the years and making this happen.”
More posts featuring Ranjit Manchanda.